Current Research & Future Challenges


Track 23: Current Research & Future Challenges



Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine discovery of novel antigens, adjuvants and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design.


    Related Conference of Current Research & Future Challenges

    May 25-26, 2022

    International Conference on Vaccine & Vaccine Research

    Auckland, Newzealand
    June 23-24, 2022

    International Congress on Vaccines and Virology

    Zurich, Switzerland
    June 23-24, 2022

    Global Summit on Vaccines & Emerging Diseases

    Zurich, Switzerland
    June 23-24, 2022

    35th World Congress on Vaccines and Immunization

    Bangkok, Thailand
    June 27-28, 2022

    Global Summit on Hepatitis Vaccine

    Zurich, Switzerland
    September 05-06, 2022

    42nd Global Summit and Expo on Vaccines & Immunology

    Paris, France
    October 05-06, 2022

    34th International Conference on Vaccines and Immunization

    Zurich, Switzerland
    November 04-05, 2022

    34th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada
    November 17-18, 2022

    2nd Global Summit on Vaccines and Immunology

    Berlin, Germany

    Current Research & Future Challenges Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in